Pacira BioSciences (PCRX) Change in Acquisitions & Divestments (2011 - 2026)

Pacira BioSciences' Change in Acquisitions & Divestments history runs 16 years deep, the most recent figure standing at $22.5 million for Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments fell 67.51% year-over-year to $22.5 million; the TTM figure through Mar 2026 stood at $227.1 million (up 10.51% YoY), while the FY2025 annual figure was $273.8 million, up 52.48% from the prior year.
• Change in Acquisitions & Divestments for Q1 2026 stood at $22.5 million, down from $47.1 million in the prior quarter.
• The five-year high for Change in Acquisitions & Divestments was $126.2 million in Q1 2023, with the low at $22.5 million in Q1 2026.
• The 5-year median for Change in Acquisitions & Divestments is $50.2 million (2024), against an average of $59.4 million.
• Peak annual rise in Change in Acquisitions & Divestments reached 146.2% in 2022, while the deepest fall reached 80.57% in 2022.
• Pacira BioSciences' Change in Acquisitions & Divestments stood at $84.9 million in 2022, then slumped by 57.5% to $36.1 million in 2023, then soared by 30.05% to $46.9 million in 2024, then rose by 0.42% to $47.1 million in 2025, then sank by 52.27% to $22.5 million in 2026.
• Business Quant data shows PCRX's Change in Acquisitions & Divestments at $22.5 million in Q1 2026, $47.1 million in Q4 2025, and $86.2 million in Q3 2025.